These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15163920)

  • 21. Aldose reductase gene polymorphisms and diabetic retinopathy susceptibility.
    Abhary S; Burdon KP; Laurie KJ; Thorpe S; Landers J; Goold L; Lake S; Petrovsky N; Craig JE
    Diabetes Care; 2010 Aug; 33(8):1834-6. PubMed ID: 20424224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy.
    Ezzidi I; Mtiraoui N; Mohamed MB; Mahjoub T; Kacem M; Almawi WY
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):542-6. PubMed ID: 17973941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The association of variable number of tandem repeats polymorphism in the endothelial nitric oxide synthase gene and diabetic retinopathy].
    She C; Yang X; Gu H; Deng Y; Xu J; Ma K; Liu N
    Zhonghua Yan Ke Za Zhi; 2015 May; 51(5):338-43. PubMed ID: 26311693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction.
    Joshi MS; Berger PJ; Kaye DM; Pearson JT; Bauer JA; Ritchie RH
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):253-61. PubMed ID: 23448535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Z-2 aldose reductase allele and diabetic retinopathy in India.
    Kumaramanickavel G; Sripriya S; Ramprasad VL; Upadyay NK; Paul PG; Sharma T
    Ophthalmic Genet; 2003 Mar; 24(1):41-8. PubMed ID: 12660865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association study between diabetic retinopathy and aldose reductase gene polymorphism in Tunisians].
    Zghal-Mokni I; Arfa I; Elloumi-Zghal H; Abid A; Amrouche-Rached C; Kaabi B; Chakroun S; Blousa-Chabchoub S; Gaïgi S; Ayed S; Jeddi A; Dellagi K; Abdelhak S
    J Fr Ophtalmol; 2005 Apr; 28(4):386-90. PubMed ID: 15973199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes.
    Morris BJ; Markus A; Glenn CL; Adams DJ; Colagiuri S; Wang L
    J Mol Med (Berl); 2002 Feb; 80(2):96-104. PubMed ID: 11907646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Relationship Between Aldose Reductase C106T Polymorphism and Diabetic Retinopathy: An Updated Meta-Analysis.
    Zhou M; Zhang P; Xu X; Sun X
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2279-89. PubMed ID: 25722213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes.
    Awata T; Neda T; Iizuka H; Kurihara S; Ohkubo T; Takata N; Osaki M; Watanabe M; Nakashima Y; Sawa T; Inukai K; Inoue I; Shibuya M; Mori K; Yoneya S; Katayama S
    Diabetes Care; 2004 Sep; 27(9):2184-90. PubMed ID: 15333482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus.
    Yang B; Cross DF; Ollerenshaw M; Millward BA; Demaine AG
    J Diabetes Complications; 2003; 17(1):1-6. PubMed ID: 12505748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics and diabetic retinopathy.
    Schwartz SG; Brantley MA; Flynn HW
    Curr Diabetes Rev; 2013 Jan; 9(1):86-92. PubMed ID: 22950970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India.
    Uthra S; Raman R; Mukesh BN; Padmaja Kumari R; Paul PG; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
    Ophthalmic Genet; 2007 Jun; 28(2):77-81. PubMed ID: 17558849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variations in vascular endothelial growth factor and endothelial nitric oxide synthase and their contributions to human disease.
    Gerritsen ME
    Microcirculation; 2005; 12(1):129-140. PubMed ID: 15825252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes.
    Santos KG; Tschiedel B; Schneider J; Souto K; Roisenberg I
    Diabetes Res Clin Pract; 2003 Aug; 61(2):133-6. PubMed ID: 12951282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of AC(n) and C(-106)T polymorphisms of the aldose reductase gene in Brazilian patients with DM1 and susceptibility to diabetic retinopathy.
    Richeti F; Noronha RM; Waetge RT; de Vasconcellos JP; de Souza OF; Kneipp B; Assis N; Rocha MN; Calliari LE; Longui CA; Monte O; de Melo MB
    Mol Vis; 2007 May; 13():740-5. PubMed ID: 17563730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic Retinopathy and Vascular Endothelial Growth Factor Gene Insertion/Deletion Polymorphism.
    Khan SZ; Ajmal N; Shaikh R
    Can J Diabetes; 2020 Apr; 44(3):287-291. PubMed ID: 31859041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients.
    Bleda S; De Haro J; Varela C; Esparza L; Ferruelo A; Acin F
    Diab Vasc Dis Res; 2012 Jan; 9(1):68-74. PubMed ID: 22064697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.